Related Experiment Videos
The syndrome of cardiac cachexia
Stefan D Anker1, Rakesh Sharma
1Franz Volhard Klinik (Charité, Campus Berlin-Buch) at Max Delbrück Centrum for Molecular Medicine, Berlin, Germany. s.anker@ic.ac.uk
International Journal of Cardiology
|August 7, 2002
Summary
Cardiac cachexia, a serious complication of chronic heart failure (CHF), involves significant body wasting and poor prognosis. Understanding its neuroendocrine and immune basis is key to developing future treatments.
Area of Science:
- Cardiology
- Metabolic Disorders
- Physiology
Background:
- Cardiac cachexia, characterized by body wasting, is a recognized complication of chronic heart failure (CHF).
- This condition is associated with a poor prognosis, irrespective of disease severity or patient age.
- Cachectic patients experience loss of lean, fat, and bone tissue, leading to reduced strength and increased fatigue.
Purpose of the Study:
- To review the current understanding of cardiac cachexia in chronic heart failure.
- To explore the pathophysiological mechanisms, including neurohormonal and immune abnormalities.
- To highlight the implications for prognosis and potential future therapeutic strategies.
Main Methods:
- Review of existing literature on cardiac cachexia in CHF.
- Analysis of pathophysiological factors including neuroendocrine and immune markers.
- Synthesis of evidence regarding the catabolic/anabolic imbalance.
Main Results:
- Cardiac cachexia involves generalized loss of lean, fat, and bone tissue.
- Neurohormonal abnormalities (elevated cortisol, catecholamines, aldosterone) and immune dysregulation (increased cytokines like TNF-alpha) are implicated.
- A catabolic/anabolic imbalance is considered central to the wasting process.
Conclusions:
- Cardiac cachexia is a multifactorial disorder in CHF with significant prognostic implications.
- Neuroendocrine and immune pathways are critical in its pathophysiology.
- Further understanding may pave the way for novel therapeutic interventions.